Amylin receptor agonism protects against metabolic side effects of acute olanzapine
Sign Up to like & getrecommendations! Published in 2023 at "Physiology"
DOI: 10.1152/physiol.2023.38.s1.5730313
Abstract: Olanzapine is a second-generation antipsychotic (SGA) used in the treatment of schizophrenia and several on- and off-label conditions. While effective in reducing psychoses, acute olanzapine treatment causes rapid hyperglycemia, insulin resistance, and dyslipidemia and these… read more here.
Keywords: acute olanzapine; physiology; olanzapine induced; amylin ... See more keywords